JYNT on Nasdaq
JOINT Corp
In its 2026 annual report the company says: “We are a growing franchisor and operator of chiropractic clinics that uses a private pay, non-insurance, cash-based model. We have created a growing network of modern, consumer-friendly chiropractic clinics operated or managed by franchisees and by us that employ licensed chiropractors. Our model enables us to price our services below most competitors’ pricing for similar services and below most insurance co-payment levels (i.e., below the patient co-payment required for an insurance-covered service).”3 It is headquartered in Scottsdale, Arizona.1 Its shares trade on Nasdaq under the symbol JYNT.1
Price unavailable
Last updated Oct 21, 2026.
Overview
Compare with Acacia Research, Digital Turbine or Royalty Management Holding Corp, or pick any stock.
- TickerJYNT on Nasdaq1
- IndustryPatent Owners & Lessors1
- HeadquartersScottsdale, Arizona1
- Incorporated inDE2
- Business address16767 N Perimeter Drive, Suite 110, Scottsdale, Az 852602
- Filer categoryNon-accelerated filer, Smaller reporting company2
See how the biggest companies compare on our leaderboards
We are a growing franchisor and operator of chiropractic clinics that uses a private pay, non-insurance, cash-based model. We seek to be the leading provider of chiropractic care in the markets we serve and to become the most recognized brand in our industry. We delivered over 14.4 million patient visits in 2025, down from 14.7 million patient visits in 2024, generating over $532.4 million and $530.3 million of system-wide sales, respectively, across our highly franchised network. We will continue the franchise-focused expansion of chiropractic clinics in key markets throughout North America and potentially abroad. We strive to accomplish our mission by making quality care readily available and affordable in a retail setting. We have created a growing network of modern, consumer-friendly chiropractic clinics operated or managed by franchisees and by us that employ licensed chiropractors.…3 From its latest annual report
Financials
From the company’s reports to the SEC. Every number links to the filing it came from.
Key numbers, fiscal 2025
What sells
Revenue by product, business segment and region, as the company reports it to the SEC.
Products and services
Royalty brought in 60% of the revenue JOINT Corp broke down this way in fiscal 2025.
Products and services by year
| Products and services | 2024 | 2025 |
|---|---|---|
| Royalty | $32.1M | $33.2M |
| Advertising | $9.2M | $10.5M |
| Technology Service | $5.7M | $6.0M |
| Franchise | $3.0M | $3.4M |
| Product and Service, Other | $2.2M | $1.8M |
Where the money goes
Where each dollar of revenue went, fiscal 2025
- Cost of revenue19¢$11.2M
- Selling, general and admin76¢$44.6M
- Income tax0¢$38.7K
- Profit5¢$2.9M
Out of $54.9M in revenue.4
Where each dollar of operating cash went, fiscal 2025
- Capital spending12¢$1.5M
- Share buybacks88¢$11.3M
Out of $1.8M of cash from operations. Spending exceeded cash from operations; the rest came from savings or borrowing.4
Financial statements
Every line of the income statement as filed: the last 2 fiscal years (annual) or 8 quarters (quarterly), latest first.4
| Period ending | 2025-12-31 | 2024-12-31 |
|---|---|---|
| Total revenues | $54.9M | $52.2M |
| Total cost of revenues | $11.2M | $11.5M |
| Selling and marketing expenses | $13.3M | $11.0M |
| Depreciation and amortization | $1.6M | $1.4M |
| General and administrative expenses | $29.6M | $30.1M |
| Total selling, general and administrative expenses | $44.6M | $42.5M |
| Net loss on disposition or impairment | $7.9K | $66.0K |
| Loss from continuing operations | -$913.4K | -$1.9M |
| Other income, net | $683.9K | $280.3K |
| Loss from continuing operations before income tax expense | -$229.5K | -$1.6M |
| Income tax expense | $38.7K | $5.6K |
| Net loss from continuing operations | -$268.2K | -$1.6M |
| Income (loss) from discontinued operations before income tax expense | $3.2M | -$4.0M |
| Income tax expense from discontinued operations | $25.2K | $210.3K |
| Net income (loss) from discontinued operations | $3.2M | -$4.2M |
| Net income (loss) | $2.9M | -$5.8M |
| Basic (in dollars per share) | -$0 | -$0 |
| Diluted (in dollars per share) | -$0 | -$0 |
| Basic (in dollars per share) | $0 | -$0 |
| Diluted (in dollars per share) | $0 | -$0 |
| Net income (loss) per common share, basic (in dollars per share) | $0.19 | -$0.39 |
| Net income (loss) per common share, diluted (in dollars per share) | $0.19 | -$0.38 |
| Basic weighted average shares outstanding (in shares) | 15.1M shares | 14.9M shares |
| Diluted weighted average shares outstanding (in shares) | 15.2M shares | 15.1M shares |
| Period ending | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
|---|---|---|---|---|---|---|---|---|
| Total revenues | $15.2M | $13.4M | $13.3M | $13.1M | $14.7M | $12.7M | $12.6M | $12.2M |
| Total cost of revenues | $2.8M | $2.7M | $2.8M | $3.0M | $3.2M | $2.8M | $2.8M | $2.7M |
| Selling and marketing expenses | $3.5M | $2.8M | $3.5M | $3.5M | $2.8M | $2.5M | $3.4M | $2.2M |
| Depreciation and amortization | $433.2K | $446.7K | $402.3K | $361.9K | $353.5K | $345.8K | $342.5K | $329.6K |
| General and administrative expenses | $7.7M | $7.3M | $7.7M | $6.9M | $7.5M | $7.5M | $7.8M | $7.3M |
| Total selling, general and administrative expenses | $11.6M | $10.6M | $11.6M | $10.8M | $10.7M | $10.3M | $11.6M | $9.9M |
| Net loss on disposition or impairment | $1.5K | $0 | $4.4K | $2.0K | $61.5K | $3.6K | $662 | $275 |
| Loss from continuing operations | $742.4K | $160.9K | -$1.1M | -$678.5K | $809.7K | -$492.8K | -$1.8M | -$426.6K |
| Other income, net | $198.2K | $139.8K | $159.9K | $185.9K | $79.7K | $83.8K | $80.5K | $36.3K |
| Loss from continuing operations before income tax expense | $940.6K | $300.7K | -$978.2K | -$492.6K | $889.4K | -$409.0K | -$1.7M | -$390.3K |
| Income tax expense | $3.5K | $10.3K | $11.4K | $13.4K | -$19.5K | $5.4K | $11.2K | $8.6K |
| Net loss from continuing operations | $937.1K | $290.4K | -$989.6K | -$506.0K | $909.0K | -$414.4K | -$1.7M | -$398.9K |
| Income (loss) from discontinued operations before income tax expense | -$224.1K | $664.3K | $1.2M | $1.6M | -$1.1M | -$2.7M | -$1.7M | $1.5M |
| Income tax expense from discontinued operations | -$278.0K | $99.6K | $100.2K | $103.4K | -$184.4K | $57.2K | $167.2K | $170.3K |
| Net income (loss) from discontinued operations | $54.0K | $564.6K | $1.1M | $1.5M | -$891.3K | -$2.8M | -$1.9M | $1.3M |
| Net income (loss) | $991.1K | $855.0K | $93.4K | $967.8K | $17.7K | -$3.2M | -$3.6M | $947.0K |
| Basic (in dollars per share) | $0 | $0 | -$0 | -$0 | $0 | -$0 | -$0 | -$0 |
| Diluted (in dollars per share) | $0 | $0 | -$0 | -$0 | $0 | -$0 | -$0 | -$0 |
| Basic (in dollars per share) | $0 | $0 | $0 | $0 | -$0 | -$0 | -$0 | $0 |
| Diluted (in dollars per share) | $0 | $0 | $0 | $0 | -$0 | -$0 | -$0 | $0 |
| Net income (loss) per common share, basic (in dollars per share) | $0.07 | $0.06 | $0.01 | $0.06 | $0.00 | -$0.21 | -$0.24 | $0.06 |
| Net income (loss) per common share, diluted (in dollars per share) | $0.07 | $0.06 | $0.01 | $0.06 | $0.00 | -$0.21 | -$0.24 | $0.06 |
Every line of the balance sheet as filed: the last 4 fiscal years (annual) or 4 quarters (quarterly), latest first.4
| Period ending | 2025-12-31 | 2025-05-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|---|
| Cash and cash equivalents | $23.6M | $25.1M | ||
| Restricted cash | $700.1K | $945.1K | ||
| Accounts receivable, net | $2.8M | $2.6M | $2.6M | |
| Deferred franchise and regional development costs, current portion | $945.9K | $1.1M | ||
| Prepaid expenses and other current assets | $1.7M | $1.8M | ||
| Discontinued operations current assets ($1.0 million and $1.1 million attributable to VIEs, respectively) | $22.2M | $43.2M | ||
| Total current assets | $52.1M | $74.6M | ||
| Property and equipment, net | $3.2M | $3.2M | ||
| Operating lease right-of-use asset | $1.6M | $555.5K | ||
| Deferred franchise and regional development costs, net of current portion | $3.8M | $4.5M | ||
| Deposits and other assets | $319.5K | $300.8K | ||
| Total assets | $61.0M | $83.2M | ||
| Accounts payable | $1.6M | $1.8M | ||
| Accrued expenses | $1.5M | $1.5M | ||
| Co-op funds liability | $700.1K | $945.1K | ||
| Payroll liabilities | $4.1M | $3.6M | ||
| Operating lease liability, current portion | $194.2K | $483.3K | ||
| Deferred franchise fee revenue, current portion | $2.5M | $2.5M | ||
| Upfront regional developer fees, current portion | $277.4K | $288.1K | ||
| Other current liabilities | $611.2K | $603.2K | ||
| Discontinued operations current liabilities ($6.1 million and $7.1 million attributable to VIEs, respectively) | $21.4M | $37.4M | ||
| Total current liabilities | $32.8M | $49.0M | ||
| Operating lease liability, net of current portion | $1.8M | $311.7K | ||
| Deferred franchise fee revenue, net of current portion | $10.9M | $12.5M | ||
| Upfront regional developer fees, net of current portion | $355.6K | $672.3K | ||
| Total liabilities | $45.9M | $62.5M | ||
| Series A preferred stock, $0.001 par value; 50,000 shares authorized, zero issued and outstanding, respectively | $0 | $0 | ||
| Common stock, $0.001 par value; 20,000,000 shares authorized, 15,471,715 shares issued and 14,142,626 shares outstanding and 15,192,893 shares issued and 15,159,878 shares outstanding, respectively | $15.5K | $15.2K | ||
| Additional paid-in capital | $52.0M | $49.2M | ||
| Treasury stock 1,329,089 shares and 33,015 shares, at cost, respectively | -$12.2M | -$870.1K | ||
| Accumulated deficit | -$24.8M | -$27.7M | ||
| Total The Joint Corp. stockholders equity | $15.1M | $20.7M | ||
| Non-controlling Interest | $25.0K | $25.0K | ||
| Total equity | $15.1M | $20.7M | $24.8M | |
| Total liabilities and stockholders equity | $61.0M | $83.2M | ||
| Series A preferred stock, par value (in dollars per share) | $0.00 | $0.00 | ||
| Series A preferred stock, shares authorized (in shares) | 50.0K shares | 50.0K shares | ||
| Series A preferred stock, shares issued (in shares) | 0 shares | 0 shares | ||
| Series A preferred stock, shares outstanding (in shares) | 0 shares | 0 shares | ||
| Common stock, par value (in dollars per share) | $0.00 | $0.00 | $0.00 | |
| Common stock, shares authorized (in shares) | 20.0M shares | 20.0M shares | ||
| Common stock, shares issued (in shares) | 15.5M shares | 15.2M shares | ||
| Common stock, shares outstanding (in shares) | 14.1M shares | 15.2M shares | ||
| Treasury stock, shares (in shares) | 1.3M shares | 33.0K shares |
| Period ending | 2025-12-31 | 2025-05-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|---|
| Cash and cash equivalents | $23.6M | $25.1M | ||
| Restricted cash | $700.1K | $945.1K | ||
| Accounts receivable, net | $2.8M | $2.6M | $2.6M | |
| Deferred franchise and regional development costs, current portion | $945.9K | $1.1M | ||
| Prepaid expenses and other current assets | $1.7M | $1.8M | ||
| Discontinued operations current assets ($1.0 million and $1.1 million attributable to VIEs, respectively) | $22.2M | $43.2M | ||
| Total current assets | $52.1M | $74.6M | ||
| Property and equipment, net | $3.2M | $3.2M | ||
| Operating lease right-of-use asset | $1.6M | $555.5K | ||
| Deferred franchise and regional development costs, net of current portion | $3.8M | $4.5M | ||
| Deposits and other assets | $319.5K | $300.8K | ||
| Total assets | $61.0M | $83.2M | ||
| Accounts payable | $1.6M | $1.8M | ||
| Accrued expenses | $1.5M | $1.5M | ||
| Co-op funds liability | $700.1K | $945.1K | ||
| Payroll liabilities | $4.1M | $3.6M | ||
| Operating lease liability, current portion | $194.2K | $483.3K | ||
| Deferred franchise fee revenue, current portion | $2.5M | $2.5M | ||
| Upfront regional developer fees, current portion | $277.4K | $288.1K | ||
| Other current liabilities | $611.2K | $603.2K | ||
| Discontinued operations current liabilities ($6.1 million and $7.1 million attributable to VIEs, respectively) | $21.4M | $37.4M | ||
| Total current liabilities | $32.8M | $49.0M | ||
| Operating lease liability, net of current portion | $1.8M | $311.7K | ||
| Deferred franchise fee revenue, net of current portion | $10.9M | $12.5M | ||
| Upfront regional developer fees, net of current portion | $355.6K | $672.3K | ||
| Total liabilities | $45.9M | $62.5M | ||
| Series A preferred stock, $0.001 par value; 50,000 shares authorized, zero issued and outstanding, respectively | $0 | $0 | ||
| Common stock, $0.001 par value; 20,000,000 shares authorized, 15,471,715 shares issued and 14,142,626 shares outstanding and 15,192,893 shares issued and 15,159,878 shares outstanding, respectively | $15.5K | $15.2K | ||
| Additional paid-in capital | $52.0M | $49.2M | ||
| Treasury stock 1,329,089 shares and 33,015 shares, at cost, respectively | -$12.2M | -$870.1K | ||
| Accumulated deficit | -$24.8M | -$27.7M | ||
| Total The Joint Corp. stockholders equity | $15.1M | $20.7M | ||
| Non-controlling Interest | $25.0K | $25.0K | ||
| Total equity | $15.1M | $20.7M | $24.8M | |
| Total liabilities and stockholders equity | $61.0M | $83.2M | ||
| Series A preferred stock, par value (in dollars per share) | $0.00 | $0.00 | ||
| Series A preferred stock, shares authorized (in shares) | 50.0K shares | 50.0K shares | ||
| Series A preferred stock, shares issued (in shares) | 0 shares | 0 shares | ||
| Series A preferred stock, shares outstanding (in shares) | 0 shares | 0 shares | ||
| Common stock, par value (in dollars per share) | $0.00 | $0.00 | $0.00 | |
| Common stock, shares authorized (in shares) | 20.0M shares | 20.0M shares | ||
| Common stock, shares issued (in shares) | 15.5M shares | 15.2M shares | ||
| Common stock, shares outstanding (in shares) | 14.1M shares | 15.2M shares | ||
| Treasury stock, shares (in shares) | 1.3M shares | 33.0K shares |
Cash flow is reported year to date, not quarter by quarter, so there are no separate quarterly figures.
Every line of the cash flow as filed: the last 2 fiscal years, latest first.4
| Period ending | 2025-12-31 | 2024-12-31 |
|---|---|---|
| Net income (loss) | $2.9M | -$5.8M |
| Depreciation and amortization | $1.7M | $4.7M |
| Net loss on disposition or impairment | $5.4M | $7.8M |
| Net franchise fees recognized upon termination of franchise agreements | -$347.1K | -$239.3K |
| Deferred income taxes | $93.1K | -$55.6K |
| Provision for credit losses | $286.2K | $220.9K |
| Stock-based compensation expense | $1.3M | $1.7M |
| Accounts receivable | $1.5M | -$1.6M |
| Prepaid expenses and other current assets | -$35.4K | $101.2K |
| Deferred franchise costs | $547.2K | $499.3K |
| Deposits and other assets | -$5.3K | $8.8K |
| Accounts payable | -$391.1K | $68.3K |
| Accrued expenses | -$3.0M | $4.6M |
| Payroll liabilities | -$839.9K | $2.4M |
| Operating leases | -$5.1M | -$3.8M |
| Deferred revenue | -$1.4M | -$597.5K |
| Upfront regional developer fees | -$285.4K | -$421.2K |
| Other liabilities | -$543.7K | -$121.4K |
| Net cash provided by operating activities | $1.8M | $9.4M |
| Proceeds from sale of clinics | $7.8M | $554.1K |
| Purchase of property and equipment | -$1.5M | -$1.2M |
| Net cash provided by (used in) investing activities | $6.3M | -$631.5K |
| Payments of finance lease obligations | -$4.4K | -$25.5K |
| Purchases of treasury stock under employee stock plans | -$8.4K | -$9.6K |
| Purchases of common stock under stock repurchase programs | -$11.3M | $0 |
| Proceeds from exercise of stock options | $1.5M | $33.7K |
| Repayment of Debt under the Credit Agreement | $0 | -$2.0M |
| Net cash used in financing activities | -$9.8M | -$2.0M |
| (Decrease) increase in cash, cash equivalents and restricted cash | -$1.7M | $6.8M |
| Interest | $50.7K | $69.4K |
| Income taxes | $626.8K | $610.5K |
| Unpaid purchases of property and equipment | $245.2K | $124.7K |
| Stock option exercise receivable | $0 | $896.8K |
No quarter-by-quarter statement was filed.
Corporate structure
JOINT Corp sits at the top of its group. 1 entity, 1 country on record. Switch between the flow chart and the network, and select any entity to see its details.
Major holders of JOINT Corp
- BlackRock Filed SCHEDULE 13G/A on JOINT Corp, latest Jul 28, 2026 (10 filings since Jan 26, 2022)
- Charles E. Jobson Filed SCHEDULE 13G/A on JOINT Corp, latest May 15, 2026 (5 filings since Jun 11, 2025)
- VANGUARD GROUP INC Filed SCHEDULE 13G/A on JOINT Corp, latest Mar 27, 2026 (4 filings since Feb 10, 2022)
- Bandera Partners LLC Filed SCHEDULE 13D/A on JOINT Corp, latest Mar 16, 2026 (11 filings since Feb 14, 2022)
- Skylands Capital, LLC Filed SCHEDULE 13G on JOINT Corp, latest Jan 8, 2026 (2 filings since Jul 10, 2025)
- MILLENNIUM MANAGEMENT LLC Filed SC 13G/A on JOINT Corp, latest Jan 12, 2024 (2 filings since Jan 13, 2023)
- ALGER ASSOCIATES INC Filed SC 13G/A on JOINT Corp, latest Jun 10, 2022 (4 filings since Oct 8, 2021)
- SW Investment Management LLC Filed SC 13G/A on JOINT Corp, latest Feb 14, 2022
- JOINT Corp Scottsdale, Arizona
Built from major holders from Schedules 13D and 13G. Each entity in the chart links to its source.
What it owns
What JOINT Corp reports owning in its annual reports to the SEC: buildings, land and equipment, real estate and locations, investments, intangible assets and inventory, at the end of its latest fiscal year and a year before.
Property and equipment
| Item | Latest | A year before | Change |
|---|---|---|---|
| Construction in progress | $990.1K4 Dec 31, 2025 | $751.9K4 Dec 31, 2024 | +31.7% |
| Property and equipment, net | $3.2M4 Dec 31, 2025 | $3.2M4 Dec 31, 2024 | −1.5% |
| Operating-lease assets (leased space) | $1.6M4 Dec 31, 2025 | $555.5K4 Dec 31, 2024 | +183.0% |
Investments
Properties, in its own words
We lease the property for our corporate headquarters and all of the properties for our company-owned or managed clinics. As of December 31, 2025, we leased 80 facilities in which we operate, with our corporate headquarters being the only leased property that will remain after the completion of our refranchising strategy. We are obligated under three additional leases for facilities in which we have ceased clinic operations.
Our corporate headquarters are located at 16767 N. Perimeter Center Drive, Suite 110, Scottsdale, Arizona 85260. The term of our lease for this location expires on May 31, 2031. The primary functions performed at our corporate headquarters are finance and accounting, treasury, marketing, operations, human resources, information systems support and legal.
The rest of Item 2
We are also obligated under non-cancellable leases for the clinics that we own or manage. Our clinics are on average 1,200 square feet. Our clinic leases generally have an initial term of five years, include one to two options to renew the term for five years each, and require us to pay a proportionate share of real estate taxes, insurance, common area maintenance charges and other operating costs.
Item 2 of the 10-K filed Mar 13, 2026.3
Leadership
Who has led JOINT Corp, and when. Pick a name to see everywhere that person has worked.
Chief executive
Chief financial officer
Chief operating officer
- Chief executive officerPeter D. Holt Jul 13, 2016 to May 24, 202412
- Chief executive officerJohn B. Richards Nov 10, 2014 to Mar 28, 201613
- PresidentPeter D. Holt May 11, 2017 to May 24, 202414
- PresidentDavid M. Orwasher Nov 10, 2014 to Nov 10, 201415
- Chief financial officerJake Singleton Nov 8, 2018 to now16
- Chief financial officerJohn P. Meloun Nov 17, 2016 to Jul 2, 201817
- Chief financial officerFrancis T. Joyce Dec 22, 2014 to Mar 22, 201618
- Chief operating officerPeter D. Holt May 3, 2016 to May 4, 201619
- Chief operating officerDavid M. Orwasher Nov 10, 2014 to Nov 10, 201415
Board members and other officers (21)
- OfficerSanjiv Kumar Razdan Oct 16, 2024 to now20
- Chief Dev. & Strategy OfficerDavid M. Orwasher Mar 15, 2016 to Sep 26, 201621
- Chief Marketing OfficerCatherine B. Hall Nov 10, 2014 to Nov 10, 201422
- Board memberMilind Pant Jun 3, 2026 to now23
- Board memberSandra R. Karrmann Jun 5, 2025 to now24
- Board memberChristopher M. Grandpre Jul 23, 2025 to now25
- Board memberSanjiv Kumar Razdan Oct 16, 2024 to now20
- Board memberGlenn J. Krevlin Jun 4, 2019 to May 24, 202426
- Board memberAbe Hong Jun 5, 2018 to now27
- Board memberMatthew E. Rubel Jun 6, 2017 to now28
- Board memberSuzanne M. Decker Jun 12, 2017 to now29
- Board memberPeter D. Holt Aug 30, 2016 to May 24, 202430
- Board memberBret Sanders Apr 22, 2015 to Jun 6, 201731
- Board memberJames H. Amos Jr. Sep 23, 2015 to May 31, 202232
- Board memberRichard A. Kerley Sep 23, 2015 to Jun 5, 201833
- Board memberCraig Colmar Nov 10, 2014 to May 10, 201634
- Board memberJohn B. Richards Nov 10, 2014 to Mar 28, 201613
- Board memberJohn Leonesio Nov 10, 2014 to Feb 3, 201635
- Board memberRonald Davella V. Nov 10, 2014 to now36
- Board memberSteve Colmar Nov 10, 2014 to May 10, 201637
- Board memberWilliam R. Fields Nov 10, 2014 to May 10, 201638
Timeline
- Oct 1, 20268-K Entered a material agreement39
- Aug 6, 20268-K Results of operations; Regulation FD disclosure40
- May 21, 20268-K Shareholder vote41
- May 7, 20268-K Entered a material agreement; Results of operations; New debt or obligation42
- May 1, 20268-K Other events43
- Apr 24, 20268-K Entered a material agreement44
- Mar 12, 20268-K Results of operations; Regulation FD disclosure45
- Jan 12, 20268-K Entered a material agreement46
- Jan 9, 20268-K Entered a material agreement47
- Dec 11, 20258-K Entered a material agreement; Ended a material agreement48
- Nov 6, 20258-K Entered a material agreement; Results of operations; Regulation FD disclosure49
- Oct 6, 20258-K Entered a material agreement; New debt or obligation50
- Jul 13, 2016New chief executive Peter D. Holt becomes CEO12
- Nov 10, 2014New chief executive John B. Richards becomes CEO13
Calendar
Coming up
- Nov 5, 2026Reports results for the quarter ending Sep/2026 A year earlier it reported $0.02 a share, on Nov 6, 2025.51
When it reported results
- Aug 6, 2026Reported quarterly or annual results40
- May 7, 2026Reported quarterly or annual results42
- Mar 12, 2026Reported quarterly or annual results45
- Nov 6, 2025Reported quarterly or annual results49
- Aug 7, 2025Reported quarterly or annual results52
- Jul 30, 2025Reported quarterly or annual results53
- May 8, 2025Reported quarterly or annual results54
- Mar 13, 2025Reported quarterly or annual results55
Upcoming dates from Nasdaq's calendar; past results from the company's 8-K filings (Item 2.02). The full markets calendar
Filings
221 filings to the SEC since October 2021: 7 annual reports, 17 quarterly reports, 52 major events, 87 insider forms, 39 large holders, 19 other. The latest 20:
- Oct 1, 20268-K EDGAR
- Aug 7, 202610-Q EDGAR
- Aug 6, 20268-K EDGAR
- Jul 28, 2026SCHEDULE 13G/A EDGAR
- Jun 12, 20264 EDGAR
- Jun 3, 20264 EDGAR
- Jun 3, 20263 EDGAR
- May 22, 20264 EDGAR
- May 22, 20264 EDGAR
- May 22, 20264 EDGAR
- May 22, 20264 EDGAR
- May 21, 20268-K EDGAR
- May 15, 2026SCHEDULE 13G/A EDGAR
- May 14, 20264 PRIMARY DOCUMENT EDGAR
- May 8, 202610-Q EDGAR
- May 7, 20268-K EDGAR
- May 1, 20268-K EDGAR
- Apr 24, 20268-K EDGAR
- Apr 23, 2026SCHEDULE 13G/A EDGAR
- Apr 23, 20264 PRIMARY DOCUMENT EDGAR
The 221 filings since October 2021 can be filtered by form type and year here when JavaScript is on.
Every filing from the last five years, summarized. The full record is on SEC EDGAR.
Insider trades
78 open-market trades by officers, directors and large owners since October 2021: 78 buys and 0 sales. Grants, option exercises and gifts are left out.
| Date | Who | Trade | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| May 13, 2026 | JOBSON CHARLES E10% owner | Buy | 20,375 | $8.57 | $174.6K | Form 4 |
| May 12, 2026 | JOBSON CHARLES E10% owner | Buy | 127,676 | $8.57 | $1.1M | Form 4 |
| Apr 21, 2026 | JOBSON CHARLES E10% owner | Buy | 509 | $8.58 | $4.4K | Form 4 |
| Feb 12, 2026 | JOBSON CHARLES E10% owner | Buy | 15,397 | $8.50 | $130.9K | Form 4 |
| Feb 11, 2026 | JOBSON CHARLES E10% owner | Buy | 448 | $8.70 | $3.9K | Form 4 |
| Jan 26, 2026 | JOBSON CHARLES E10% owner | Buy | 725 | $10.00 | $7.2K | Form 4 |
| Jan 23, 2026 | JOBSON CHARLES E10% owner | Buy | 16,753 | $10.00 | $167.5K | Form 4 |
| Jan 6, 2026 | JOBSON CHARLES E10% owner | Buy | 5,240 | $8.89 | $46.6K | Form 4 |
| Jan 2, 2026 | JOBSON CHARLES E10% owner | Buy | 1,393 | $8.70 | $12.1K | Form 4 |
| Dec 31, 2025 | JOBSON CHARLES E10% owner | Buy | 11 | $8.70 | $96 | Form 4 |
| Dec 5, 2025 | JOBSON CHARLES E10% owner | Buy | 10,000 | $8.41 | $84.1K | Form 4 |
| Dec 1, 2025 | JOBSON CHARLES E10% owner | Buy | 13,000 | $8.41 | $109.3K | Form 4 |
| Nov 25, 2025 | JOBSON CHARLES E10% owner | Buy | 2,081 | $8.43 | $17.5K | Form 4 |
| Nov 24, 2025 | JOBSON CHARLES E10% owner | Buy | 4,680 | $8.36 | $39.1K | Form 4 |
| Nov 21, 2025 | JOBSON CHARLES E10% owner | Buy | 10,000 | $8.50 | $85.0K | Form 4 |
| Aug 20, 2025 | Grandpre Christopher MDirector | Buy | 10,000 | $10.41 | $104.1K | Form 4 |
| Aug 18, 2025 | Grandpre Christopher MDirector | Buy | 10,000 | $10.70 | $107.0K | Form 4 |
| Aug 15, 2025 | Grandpre Christopher MDirector | Buy | 14,388 | $10.88 | $156.5K | Form 4 |
| Sep 21, 2023 | Bandera Partners LLC10% owner | Buy | 218,101 | $9.60 | $2.1M | Form 4 |
| Sep 20, 2023 | Bandera Partners LLC10% owner | Buy | 22,666 | $9.50 | $215.3K | Form 4 |
All 78 trades can be filtered by person here when JavaScript is on.
From Forms 4 filed with the SEC.
Major holders
Investors who own more than 5% of the shares must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively.
- BlackRockSCHEDULE 13G/A, 10 filings Jan 26, 2022 to Jul 28, 202656
- Charles E. JobsonSCHEDULE 13G/A, 5 filings Jun 11, 2025 to May 15, 202657
- VANGUARD GROUP INCSCHEDULE 13G/A, 4 filings Feb 10, 2022 to Mar 27, 202658
- Bandera Partners LLCSCHEDULE 13D/A, 11 filings Feb 14, 2022 to Mar 16, 202659
- Skylands Capital, LLCSCHEDULE 13G, 2 filings Jul 10, 2025 to Jan 8, 202660
- MILLENNIUM MANAGEMENT LLCSC 13G/A, 2 filings Jan 13, 2023 to Jan 12, 202461
- ALGER ASSOCIATES INCSC 13G/A, 4 filings Oct 8, 2021 to Jun 10, 202262
- SW Investment Management LLCSC 13G/A, 1 filing Feb 14, 202263
Executive pay
What the company paid its top executives, from the summary compensation table in its proxy statement. Total pay includes salary, bonus, stock and option awards and other pay, as the company valued them.
| Year | Executive | Age | Salary | Total pay |
|---|---|---|---|---|
| 2025 | Sanjiv RazdanPresident and Chief Executive Officer | $550.0K | $1.8M64 | |
| 2025 | Jake SingletonFormer Chief Financial Officer | $194.3K | $646.9K64 | |
| 2025 | Scott BowmanChief Financial Officer | $208.5K | $599.2K64 | |
| 2024 | Sanjiv RazdanPresident and Chief Executive Officer | $127.7K | $864.2K64 | |
| 2024 | Jake SingletonFormer Chief Financial Officer | $330.3K | $672.6K64 |
Held by these funds
The largest holders among investment managers' 13F reports for the quarter ending Jun 30, 2026, the top 25 of 84. Change is in shares since the quarter before.
13F reports cover disclosed long positions in U.S. stocks only.
SEC filer profile
How JOINT Corp is registered with the Securities and Exchange Commission, from its EDGAR record and the cover page of its latest annual report.
- Name on EDGARJOINT Corp1
- CIK0001612630
- Employer ID (EIN)90-05441603
- Filer statusNon-accelerated filer not an emerging growth company; a smaller reporting company; not a shell company3
- Incorporated inDelaware3
- Fiscal year endsDecember 311
- Industry code (SIC)6794 Patent Owners & Lessors1
- SEC reviewing officeOffice of Real Estate & Construction, Division of Corporation Finance1
- Business address16767 N Perimeter Drive, Suite 110, Scottsdale, AZ 852601
- Phone480 245 59601
- Shares outstanding14,143,154 as of Aug 3, 202611
- Public float$172.5M as of Jun 30, 20253
- AuditorBDO USA, P.C., Phoenix, Arizona PCAOB ID 243; no auditor attestation of internal control over financial reporting3
- On EDGAR sinceJul 11, 20141
- Filings624 in all: 4 (239), 8-K (138), SC 13G/A (42), 10-Q (36), 3 (29), SC 13G (17), CORRESP (14), 10-K (12)1
All 39 form types
DEF 14A (12), 8-K/A (10), UPLOAD (8), S-1/A (6), SCHEDULE 13G/A (6), S-8 (5), SC 13D/A (5), 3/A (3), 5 (3), DEFA14A (3), NT 10-Q (3), SCHEDULE 13D/A (3), SCHEDULE 13G (3), 10-K/A (2), 10-Q/A (2), 144 (2), 4/A (2), 424B1 (2), DEFR14A (2), EFFECT (2), S-1 (2), SC 13D (2), 8-A12B (1), CERTNAS (1), DRS (1), DRS/A (1), DRSLTR (1), NT 10-K (1), S-1MEF (1), SC 14N (1), SC 14N/A (1)
- Latest filingsAnnual report (10-K) Mar 13, 2026
Quarterly report (10-Q) Aug 7, 2026
Proxy statement (DEF 14A) Apr 7, 2026
Latest 8-K (8-K) Oct 1, 2026
Securities registered for trading
| Class | Symbol | Exchange |
|---|---|---|
| Common Stock, $0.001 Par Value Per Share | JYNT | NASDAQ |
From the cover page of the 10-K filed Mar 13, 2026 (Section 12(b) of the Exchange Act).3
Risk factors and legal proceedings
The risks JOINT Corp names in Item 1A of its 10-K filed Mar 13, 2026: 40 risks under these headings, as written.3
- RISKS RELATED TO OPERATING OUR BUSINESS
- The nationwide labor shortage has negatively impacted our ability to recruit chiropractors and other qualified personnel, and the measures we have taken in response have reduced our net revenues.
- Inflation has led to increased labor costs and interest rates and may lead to reduced discretionary spending, all of which may negatively impact our business.
- New clinics, once opened, may not be profitable, and the increases in average clinic sales and comparable clinic sales that our franchisees have experienced in the past may not be indicative of future results.
- Our failure to manage our growth effectively could harm our business and operating results.
- Our expansion into new markets may be more costly and difficult than we currently anticipate, which would result in slower growth than we expect.
- Opening new clinics in existing markets may negatively affect revenue at existing clinics.
- Damage to our reputation or our brand in existing or new markets could negatively impact our business, financial condition and results of operations.
- Our marketing programs may not be successful.
- We will be subject to risks associated with leasing space subject to long-term non-cancelable leases for clinics that we intend to operate.
- Changes in economic conditions and adverse weather and other unforeseen conditions could materially affect our ability to maintain or increase sales at our clinics.
- RISKS RELATED TO USE OF THE FRANCHISE BUSINESS MODEL
The other 30 risks
- Our dependence on the success of our franchisees exposes us to risks, including the loss of royalty revenue and harm to our brand.
- Our franchisees are independent operators over whom we have limited control.
- We are subject to the risk that our franchise agreements may be terminated or not renewed.
- Our franchisees may not meet timetables for opening their clinics, which could reduce the royalties we receive.
- Our regional developers are independent operators over whom we have limited control.
- FINANCIAL RISK FACTORS
- Our level of debt could impair our financial condition and ability to operate.
- We have identified a material weakness in our internal control over financial reporting. If we fail to maintain an effective system of internal controls over financial reporting, we may not be able to accurately report our financial results, prevent fraud, or maintain investor confidence.
- Our balance sheet includes intangible assets and goodwill. A decline in the estimated fair value of an intangible asset or a reporting unit could result in an impairment charge recorded in our operating results, which could be material.
- Our balance sheet includes a significant number of long-lived assets in our corporate clinics, including operating lease right-of-use assets and property, plant and equipment. A decline in the current and projected cash flows in our corporate clinics could result in impairment charges, which could be material.
- Our increased reliance on sources of revenue other than from company-owned or managed clinics exposes us to risks including the loss of revenue and reduction of working capital.
- We have experienced net losses and may not achieve or sustain profitability in the future.
- Any audit by the IRS with respect to our receipt of an employee retention credit (“ERC”) under The Coronavirus Aid, Relief, and Economic Security Act (the “CARES Act”) could result in additional taxes or costs to our company.
- RISKS RELATED TO INDUSTRY DYNAMICS AND COMPETITION
- Our clinics and chiropractors compete for patients in a highly competitive environment that may make it more difficult to increase patient volumes and revenues.
- Our success is dependent on the chiropractors who control the PCs, or PC owners, with whom we enter into management services agreements, and we may have difficulty locating qualified chiropractors to replace PC owners.
- RISKS RELATED TO STATE REGULATION OF THE CORPORATE PRACTICE OF CHIROPRACTIC
- Our management services agreements, under which we provide non-clinical services to affiliated PCs, could be challenged by a state or chiropractor under laws regulating the practice of chiropractic. Some state chiropractic boards have made inquiries concerning our business model or have proposed or adopted changes to their rules that could be interpreted to pose a threat to our business model.
- RISKS RELATED TO OTHER LEGAL AND REGULATORY MATTERS
- Uncertainties with federal regulations under the new presidential administration expanding the meaning of “joint employer” and evolving state laws increase our potential liability for employment law violations by our franchisees and the likelihood that we may be required to participate in collective bargaining with our franchisees’ employees.
- An increased regulatory focus on the establishment of fair franchise practices could increase our risk of liability in disputes with franchisees and the risk of enforcement actions and penalties.
- We conduct business in a heavily regulated industry, and if we fail to comply with these laws and government regulations, we could incur penalties or be required to make significant changes to our operations.
- Our chiropractors are subject to ethical guidelines and operating standards which, if not complied with, could adversely affect our business.
- We, along with our affiliated PCs and their chiropractors, are subject to malpractice and other similar claims and may be unable to obtain or maintain adequate insurance against these claims.
- Events or rumors relating to our brand names or our ability to defend successfully against intellectual property infringement claims by third parties could significantly impact our business.
- RISKS RELATED TO INFORMATION TECHNOLOGY, CYBERSECURITY AND DATA PRIVACY
- Our failure to comply with applicable federal and state data privacy and security laws could result in civil or criminal sanctions or damage awards, and the proliferation of such laws increases our costs of compliance.
- Our business model depends on proprietary and third-party management information systems that we use to, among other things, track financial and operating performance of our clinics, and any failure to successfully design and maintain these systems or implement new systems could materially harm our operations.
- If we fail to properly maintain the integrity of our data or to strategically implement, upgrade or consolidate existing information systems, our reputation and business could be materially adversely affected.
- If our security systems are breached, we may face civil liability and public perception of our security measures could be diminished, either of which would negatively affect our ability to attract and retain patients.
- We are subject to a number of risks related to credit card and debit card payments we accept.
- GENERAL RISK FACTORS
- We have restated our Previously Issued Financial Statements, which may lead to additional risks and uncertainties, including loss of investor confidence and negative impacts on our stock price.
- Short-selling strategies and negative opinions posted on the internet may drive down the market price of our common stock and could result in class action lawsuits.
- Future sales of our common stock may depress our stock price and our share price may decline due to the large number of shares eligible for future sale or exchange.
- Claims for indemnification by our directors and officers may reduce our available funds to satisfy successful third-party claims against us and may reduce the amount of money available to us.
Legal proceedings
Information regarding our legal proceedings is discussed in Note 10, Commitments and Contingencies in the Notes to the consolidated financial statements, which is incorporated herein by reference.
The opening of Item 3, Legal Proceedings.3
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1SEC EDGARJOINT Corp filings on SEC EDGAR
- 2SEC EDGARJOINT Corp filings on SEC EDGAR
- 3
- 4SEC EDGARJOINT Corp 10-K for fiscal 2025
- 5SEC EDGARJOINT Corp 10-K for fiscal 2019
- 6SEC EDGARJOINT Corp 10-K for fiscal 2020
- 7SEC EDGARJOINT Corp 10-K for fiscal 2021
- 8SEC EDGARJOINT Corp 10-K for fiscal 2022
- 9SEC EDGARJOINT Corp 10-K for fiscal 2022
- 10SEC EDGARJOINT Corp 10-Q for fiscal 2026
- 11SEC EDGARJOINT Corp 10-Q for fiscal 2026
- 12
- 13
- 14SEC EDGARPeter D. Holt, President
- 15SEC EDGARDavid M. Orwasher, President
- 16
- 17
- 18
- 19
- 20SEC EDGARSanjiv Kumar Razdan, Officer
- 21
- 22
- 23SEC EDGARMilind Pant, Board member
- 24SEC EDGARSandra R. Karrmann, Board member
- 25
- 26SEC EDGARGlenn J. Krevlin, Board member
- 27SEC EDGARAbe Hong, Board member
- 28SEC EDGARMatthew E. Rubel, Board member
- 29SEC EDGARSuzanne M. Decker, Board member
- 30SEC EDGARPeter D. Holt, Board member
- 31SEC EDGARBret Sanders, Board member
- 32SEC EDGARJames H. Amos Jr., Board member
- 33SEC EDGARRichard A. Kerley, Board member
- 34SEC EDGARCraig Colmar, Board member
- 35SEC EDGARJohn Leonesio, Board member
- 36SEC EDGARRonald Davella V., Board member
- 37SEC EDGARSteve Colmar, Board member
- 38SEC EDGARWilliam R. Fields, Board member
- 39SEC EDGAREntered a material agreement
- 40
- 41SEC EDGARShareholder vote
- 42
- 43SEC EDGAROther events
- 44SEC EDGAREntered a material agreement
- 45
- 46SEC EDGAREntered a material agreement
- 47SEC EDGAREntered a material agreement
- 48
- 49
- 50
- 51NasdaqNasdaq calendar
- 52
- 53
- 54
- 55
- 56
- 57
- 58
- 59
- 60
- 61
- 62
- 63
- 64